Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2013. The largest medical products acquisition in 2013 was Bausch & Lomb - which was acquired by Bausch Health Companies for $8.7B.
Join Mergr to view all 183 acquisitions of medical products companies in 2013, including 23 acquisitions by private equity firms, and 160 by strategics.
Nautilus Neurosciences - CAMBIA® (Diclofenac Potassium for Oral Solution) is a non-steroidal anti-inflammatory drug (NSAID) indicated for acute treatment of migraine attacks with or without aura in adults 18 years of age or older.
Nautilus Neurosciences - CAMBIA® was acquired by Assertio Therapeutics on December 17, 2013.
Join Mergr to view this profile - and discover more medical products acquisitions of companies like Nautilus Neurosciences - CAMBIA®.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.